Claim Missing Document
Check
Articles

Found 2 Documents
Search

Growth, Development and Survival Rate of The Blue Swimming Crab (Portunus pelagicus) Cultured using Different Larvae Feeds Rabby, Ahmad Fazley; Rahman, Turabur; Islam, Zahidul; Hasan, Jakia; Aktaruzzaman, Md; Rahman, Shafiqur; Karim, Ehsanul; Ali, Md Zulfikar
ILMU KELAUTAN: Indonesian Journal of Marine Sciences Vol 29, No 1 (2024): Ilmu Kelautan
Publisher : Marine Science Department Diponegoro University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14710/ik.ijms.29.1.147-155

Abstract

Blue swimming crab (Portunus pelagicus) is one of the most important commodities of softshell industry. Besides mud crab its demand as feed is increasing day by day. As a coastal dominant country, Bangladesh has a great feasibility of this species in culture, production, use and export. However, the production contribution from Bangladesh is still from natural sources and far behind in terms of farming, culture and production. Optimization of larval rearing techniques is therefore important to develop intensive hatchery rearing technique for this species. So, this study is aimed to develop larvae production technique of Portunus pelagicus with a better survival rate. Newly hatched first zoeal of Portunus pelagicus were reared using three different diets till second zoeal stage: (Treatment 1= Artemia franciscana umbrella + Rotifer (Brachionus rotundiformis); Treatment 2= Rotifer (B. rotundiformis) and Treatment 3= Artemia franciscana umbrella). Then, Artemia franciscana nauplii were used for all three treatments till they metamorphosed to crab instar. Regularly, water quality parameters were monitored and maintained and the survival and molting to next stages was observed. The result showed that, all the hatched zoea of P. pelagicus could successfully turns into crab instar stage under all the treatment applied, but the highest survival rate 6.08% was found in case of treatment 2 followed by 0.58%, 0.91%, respectively in treatment 1 and 3. In terms of metamorphosis, it took more than 15 and 14 days respectively from zoea 1 to metamorphose into megalopa for treatments 1 and 3, whereas metamorphosis from zoea 1 to megalopa in treatment 2 finished at the 12th day with a higher Larval Stage Index (LSI) value which was 4.9. Finally, at the 15th day larvae were metamorphosed into crablet for treatment 2 and 18 and 16 days required for metamorphosis into crablets for treatment 1 and 3, respectively. However, the larval feed showed a significant effect on growth and survival of P. pelagicus larvae, whereas the earlier larval stage of P. pelagicus rearing with Rotifer (B. rotundiformis) is found as the most suitable diet.
TARGETED GENE SILENCING OF KRAS ONCOGENES IN PANCREATIC CANCER USING SIRNA-LOADED GOLD NANOPARTICLES Ahmed, Shakib; Islam, Zahidul; El Balqis, Fatimah
Journal of Biomedical and Techno Nanomaterials Vol. 2 No. 4 (2025)
Publisher : Yayasan Adra Karima Hubbi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70177/jbtn.v2i4.2516

Abstract

Pancreatic cancer, predominantly driven by mutations in the KRAS oncogene, remains one of the most lethal malignancies due to its resistance to conventional therapies. RNA interference (RNAi) using small interfering RNA (siRNA) presents a powerful strategy to silence oncogenes, but its clinical application is liited by the poor stability and inefficient delivery of naked siRNA. This study aimed to develop and validate a targeted nanodelivery system using gold nanoparticles (AuNPs) to efficiently deliver KRAS-specific siRNA and induce potent gene silencing in pancreatic cancer cells. A nanoconjugate was synthesized by attaching thiol-modified siRNA targeting the G12D-mutant KRAS gene to PEGylated gold nanoparticles. The physicochemical properties of the siRNA-AuNPs were characterized. The platform’s efficacy was evaluated in vitro using the PANC-1 human pancreatic cancer cell line. KRAS expression was quantified via qRT-PCR and Western blot, while cellular viability and apoptosis were assessed using MTT and flow cytometry assays, respectively. The synthesized siRNA-AuNPs exhibited excellent stability and were efficiently internalized by the cancer cells. This targeted delivery resulted in a significant downregulation of KRAS mRNA and protein expression by over 75% (p < 0.01) compared to controls. Consequently, this oncogene silencing led to a substantial inhibition of cancer cell proliferation and a marked increase in apoptosis. Gold nanoparticles serve as a highly effective and robust vector for the targeted delivery of siRNA. This nanomedicine platform successfully silences the critical KRAS oncogene, inducing cell death in pancreatic cancer cells and representing a promising new avenue for targeted cancer therapy.